Anzeige
Mehr »
Mittwoch, 16.09.2026 - Börsentäglich über 12.000 News
Kommerzialisierung der "Super-Exosomen"
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PM

WKN: A2DVVT | ISIN: SE0005962206 | Ticker-Symbol: 28L
Frankfurt
12.08.26 | 08:08
0,000 Euro
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
PEPTONIC MEDICAL AB Chart 1 Jahr
5-Tage-Chart
PEPTONIC MEDICAL AB 5-Tage-Chart

Aktueller Chart PEPTONIC MEDICAL Aktie

Chart vergleichen mit:

Firmenname, WKN, ISIN oder Aktien-Kürzel

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%
Chart-Typ:
Zeitraum:
 
PEPTONIC MEDICAL AB-Investoren interessieren sich auch für diese Wertpapiere
Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key MetricsGenerates $1.3 billion in total revenue, representing 31.6% growth year-over-year Grows Medicare Advantage membership 31.5% year-over-year to approximately 294,100 membersRaises the midpoint of all...
► Artikel lesen
Kaplan Fox & Kilsheimer LLP: Kaplan Fox Alerts Investors of Alignment Healthcare, Inc. (ALHC) to an Investigation of Potential Securities Law ViolationsNew York, New York--(Newsfile Corp. - July 10, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or...
► Artikel lesen
Alignment Healthcare Strengthens Leadership Team to Support Long-Term Growth and Shareholder Value CreationORANGE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) today announced leadership updates that further strengthen the organization as the company continues to scale...
► Artikel lesen
PROCEPT BioRobotics Reports First Quarter 2026 Financial ResultsSAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative...
► Artikel lesen
PROCEPT BioRobotics: EAU Guidelines Upgrade Aquablation Therapy to Strong Surgical Recommendation for BPHUpdated European Association of Urology guidelines reflect growing clinical evidence supporting Aquablation therapy in the surgical treatment of benign prostatic hyperplasiaSAN JOSE, Calif., March 23...
► Artikel lesen